2 completed, 1 active not recruiting, 1 terminated. 4 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Potassium Iodide: new trials by email Literature Review of Potassium Iodide trials Research Report on Potassium Iodide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma Irinotecan, Temozolomide, Bevacizumab - Recurrent Medulloblastoma, Recurrent Ependymoma | Phase 2 | Active not recruiting | Pediatric Brain Tumor Consortium | 62 | 2022-04-04 | 2026-07-28 |
| Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars Silver diamine fluoride/ potassium iodide, Silver diamine fluoride, Resin modified glass ionomer cement - Tertiary Dentine, Indirect Pulp Capping | Phase 2 / Phase 3 | Completed | Nourhan M.Aly | 108 | 2019-11-01 | 2022-05-19 |
| Study of Bexxar <Tositumomab> Combined With External Beam Radiation Therapy Bexxar (tositumomab), External beam radiotherapy (XRT), Potassium Iodide (KI) - Lymphoma, Non-Hodgkin | Phase 2 | Terminated | Stanford University | 8 | 2007-01-01 | 2017-03-29 |
| Phase 2 Study of Bexxar in Relapsed/Refractory DLCL Bexxar, Acetaminophen, Diphenhydramine - Lymphoma | Phase 2 | Completed | Susan Knox | 9 | 2004-09-01 | 2017-03-30 |
Dentin, Secondary (1) · Ependymoma (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Medulloblastoma (1)
Nourhan M.Aly (1) · Pediatric Brain Tumor Consortium (1) · Stanford University (1) · Susan Knox (1)
United States (3) · Egypt (1)
Susan J Knox (2) · Fontana Margherita (1) · Magda El-Tekeya, PhD (1) · Marwa Baraka, M.Sc (1) · Matthias Karajannis, MD, MS (1) · Niveen Bakry, PhD (1)
UM1CA081457 (1)